DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

Antares Pharma, Inc.

NASDAQ: ATRS

+ Add to Portfolio

company name or ticker

Antares Pharma to Present at the Deutsche Bank Securities, Inc. 38th Annual Health Care Conference

5/24/2013 by DailyFinance

Antares Pharma Welcomes Marvin Samson to Board of Directors

5/23/2013 by DailyFinance

Long-Term Biotech: 3 Names To Discover Now

5/21/2013 by Seeking Alpha

2013 FDA Drug Approval Calendar

5/21/2013 by TheStreet

SmithOnStocks Opines On Stocks: May 19th Edition

5/19/2013 by Seeking Alpha

3 Most Important Upcoming FDA Decisions of 2013

The Food and Drug Administration will decide on drugs developed by Merck, Antares Pharmaceuticals, and GlaxoSmithKline in the coming months.
5/17/2013 by DailyFinance

Antares: Reiteration Of My Buy Recommendation

5/16/2013 by Seeking Alpha

Contraceptive Ring: Another Under-The-Radar Catalyst For Antares

5/15/2013 by Seeking Alpha

Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference

5/9/2013 by DailyFinance

Antares Pharma Whiffs on Revenues

Just the facts, Fool.
5/8/2013 by DailyFinance
See More Articles...